<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05618756</url>
  </required_header>
  <id_info>
    <org_study_id>5553</org_study_id>
    <nct_id>NCT05618756</nct_id>
  </id_info>
  <brief_title>CBD, Nutrient Metabolism and Energy Intake</brief_title>
  <official_title>Effects of Acute Cannabidiol (CBD) Supplementation on Nutrient Metabolism and Energy Intake in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Loughborough University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Loughborough University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CBD may affect metabolic control and energy intake. However, there is currently little data&#xD;
      regarding these specific outcomes in humans. Therefore, this study will investigate whether a&#xD;
      single 300 mg dose of CBD can improve metabolic control following a meal and/or reduce energy&#xD;
      intake at a subsequent meal. Healthy, adult volunteers will complete two conditions in a&#xD;
      crossover design, comparing outcomes following both CBD and placebo supplementation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Energy intake</measure>
    <time_frame>~5-30 minutes (time taken to eat a single meal)</time_frame>
    <description>Self-selected energy intake at an ad libitum mixed meal</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postprandial Glycaemia</measure>
    <time_frame>3 hours</time_frame>
    <description>Plasma glucose response to a mixed meal (plasma glucose concentrations and area under curve)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postprandial Triglyceridaemia</measure>
    <time_frame>3 hours</time_frame>
    <description>Plasma triglyceride response to a mixed meal (plasma triglyceride concentrations and area under curve)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postprandial Insulinaemia</measure>
    <time_frame>3 hours</time_frame>
    <description>Plasma Insulin response to a mixed meal (plasma insulin concentrations and area under curve)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Glucose Metabolism Disorders (Including Diabetes Mellitus)</condition>
  <condition>Lipid Metabolism Disorders</condition>
  <condition>Appetitive Behavior</condition>
  <arm_group>
    <arm_group_label>Cannabidiol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>300 mg CBD (KannaSwiss, Kölliken, Switzerland) dissolved in 1 ml hemp oil. Provided orally in gelatin capsules.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 ml hemp oil. Provided orally in gelatin capsules.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Acute oral CBD supplementation</intervention_name>
    <description>1 ml hemp oil containing 300 mg CBD, within gelatin capsules, ingested orally.</description>
    <arm_group_label>Cannabidiol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Acute oral placebo supplementation</intervention_name>
    <description>1 ml hemp oil containing no CBD, within gelatin capsules, ingested orally.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        • Self-report as healthy, male or female, aged 18-50, body mass index ≥18.5 and &lt;30.0&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently engage in &gt;10 hours moderate or vigorous intensity physical activity per&#xD;
             week&#xD;
&#xD;
          -  Have consumed CBD or cannabis at all within the past two months&#xD;
&#xD;
          -  Have used CBD or cannabis regularly (&gt;2x in a week) within the past four months&#xD;
&#xD;
          -  Are suffering from any clinically significant illness&#xD;
&#xD;
          -  Have regularly used tobacco within the previous 6 months (&gt; 2/week)&#xD;
&#xD;
          -  Currently use any prescription or over-the-counter medications (except for hormonal&#xD;
             contraception and simple painkillers)&#xD;
&#xD;
          -  Have given a standard blood donation within 30 days of screening&#xD;
&#xD;
          -  Are currently pregnant or lactating&#xD;
&#xD;
          -  Are allergic/intolerant to any ingredients in food items provided during the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Loughborough University</name>
      <address>
        <city>Loughborough</city>
        <state>Leicestershire</state>
        <zip>LE11 3TU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lewis James, PhD</last_name>
      <phone>+441509226305</phone>
      <email>l.james@lboro.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Lewis James, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Drusus Johnson, MSci</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>February 23, 2022</study_first_submitted>
  <study_first_submitted_qc>November 9, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2022</study_first_posted>
  <last_update_submitted>January 16, 2023</last_update_submitted>
  <last_update_submitted_qc>January 16, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Loughborough University</investigator_affiliation>
    <investigator_full_name>Lewis James</investigator_full_name>
    <investigator_title>Senior Lecturer in Nutrition</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Glucose Metabolism Disorders</mesh_term>
    <mesh_term>Lipid Metabolism Disorders</mesh_term>
    <mesh_term>Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

